A new trading day began on Friday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price up 14.03% from the previous day of trading, before settling in for the closing price of $16.32. ADPT’s price has ranged from $4.27 to $17.89 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -1.51% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 54.77%. With a float of $146.68 million, this company’s outstanding shares have now reached $152.58 million.
Adaptive Biotechnologies Corp (ADPT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.92%, while institutional ownership is 93.91%. The most recent insider transaction that took place on Nov 21 ’25, was worth 5,040,220. Before that another transaction happened on Nov 20 ’25, when Company’s Officer proposed sale 201,993 for $15.15, making the entire transaction worth $3,060,194.
Adaptive Biotechnologies Corp (ADPT) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.23 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.58% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Let’s dig in a bit further. During the last 5-days, its volume was 3.11 million. That was better than the volume of 2.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.31%.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 95.90%, which indicates a significant increase from 93.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.10 in the past 14 days, which was higher than the 0.74 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.29, while its 200-day Moving Average is $11.16. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $19.67. Second resistance stands at $20.72. The third major resistance level sits at $22.47. If the price goes on to break the first support level at $16.87, it is likely to go to the next support level at $15.12. Assuming the price breaks the second support level, the third support level stands at $14.07.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
With a market capitalization of 2.84 billion, the company has a total of 152,665K Shares Outstanding. Currently, annual sales are 178,960 K while annual income is -159,490 K. The company’s previous quarter sales were 93,970 K while its latest quarter income was 9,550 K.
